Condition category
Date applied
Date assigned
Last edited
Retrospectively registered
Overall trial status
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information



Primary contact

Dr Keir Lewis


Contact details

Respiratory Centre
Prince Philip Hospital
SA14 8QF
United Kingdom
+44 (0)1554 783133

Additional identifiers

EudraCT number number

Protocol/serial number


Study information

Scientific title

Does home telemonitoring reduce healthcare use in recurrent hospital attenders with chronic obstructive pulmonary disease (COPD)? A pilot randomised trial


Study hypothesis

To see if telemonitor deployment results in fewer admissions to hospital for chronic obstructive pulmonary disease (COPD).

Secondary outcomes:
1. To test the null hypotheses that there is no difference in primary care contacts, emergency room attendances, length of hospital admissions, Chronic Disease Management Team (CDMT) phone calls/visits, quality of life (computerised adaptive testing [CAT], EuroQol instrument [EQ5D]) scores during the 12 months 'telemedicine plus standard care' versus 12 months 'standard care alone'.
2. To record telemedicine usage/concordance during the 12-month monitoring period
3. To estimate cost-effectiveness of telemedicine using changes in EQ5D, CAT scores and healthcare contacts

Ethics approval

Dyfed Powys Local Research Ethics Committee pending approval – approval pending as of 02/11/2009

Study design

Randomised controlled cross-over trial

Primary study design


Secondary study design

Randomised controlled trial

Trial setting


Trial type


Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet.


Chronic obstructive pulmonary disease (COPD)


From hospital databases, we will identify 240 patients who have had more than two admissions to any of Prince Philip, West Wales General, Withybush and Bronglais Hospitals within the last 2 years.

Medications will be optimised if not already done. 120 will be randomised to receive telemonitors (Tm's) for 1 year whilst the other 120 receive standard care. After 1 year, the Tm's will be swapped into the homes of the second group (120) in a crossover trial for a further year of monitoring.

Once daily the patients would complete a set of questions relating to COPD symptoms and record their oxygen levels, pulse rate and temperature. The Tm automatically sends the information via a (free) telephone line to a secure internet site. The results are reviewed daily by the home COPD specialist team and if there is any signs of worsening of their condition they would intervene with a phone call followed by a visit and treatment escalation, if appropriate. We hope that earlier intervention may prevent further deterioration, requiring hospital admission or multiple GP visits. The monitors are also set up to generate an email alert to the nurses if any questions or recordings indicate a significant deterioration. All participants are aware that the Tm is not a replacement for their usual actions but to be used as an early warning system and they should seek direct help live in a severe emergency.

Intervention type



Not Applicable

Drug names

Primary outcome measures

The number of hospital admissions

Secondary outcome measures

1. Quality of life measures (EQ-5D and CA-COPD questionnaires) at baseline and every 6 months for 2 years
2. Healthcare contacts - GP visits, outpatient visits and home contacts by the community COPD nurses over the 2 years of the study
3. A cost evaluation will also be undertaken after the 2 years

Overall trial start date


Overall trial end date


Reason abandoned


Participant inclusion criteria

1. 240 still living subjects with a primary diagnosis of COPD will identified from hospital admissions database
2. Two or more admissions to any of the following hospitals in the last 2 years - Prince Philip; West Wales General; Withybush; Bronglais
3. Diagnosis and reason for admission corroborated by a member of the research team
4. We will include COPD of any severity of airflow obstruction, who have been admitted to hospital two or more times in the last 2 years
5. Participants must be at least 40 years old, either sex

Participant type


Age group




Target number of participants

240 - 120 in each of the two arms of the study

Participant exclusion criteria

1. Inability or refusal to sign informed consent
2. Less than 40 years of age
3. Life expectancy less than 2 years or cognitive/physical impairment that would preclude home telemonitoring use

Recruitment start date


Recruitment end date



Countries of recruitment

United Kingdom

Trial participating centre

Respiratory Centre
SA14 8QF
United Kingdom

Sponsor information


Hywel Dda Health Board (UK)

Sponsor details

c/o Mr Chris Tattersall
Withybush Hospital
Fishguard Road
SA61 2PZ
United Kingdom

Sponsor type

Hospital/treatment centre



Funder type


Funder name

Welsh Assembly Government (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype


Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes